AssuredPartners Investment Advisors, LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 2055492
Tampa, FL
Position in RXRX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$123,113
+$52,095 QoQ
Shares Held
33,546
+45.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#181
of 344 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AssuredPartners Investment Advisors, LLC holds $2,871,446 across 5 Biotechnology names. RXRX ranks #3 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,147 | $2,059,939 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
|
73,260 | $586,812 | |
| 3 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
33,546 | $123,113 | |
| 4 | ABCL |
AbCellera Biologics Inc.
|
10,187 | $79,967 | |
| 5 | LCTX |
Lineage Cell Therapeutics, Inc.
|
16,500 | $21,615 |
All Filings in RXRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,113 | 33,546 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $71,018 | 23,133 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $84,233 | 20,595 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||